Cargando…
Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair
OBJECTIVE: Esophageal adenocarcinoma (EAC) continues to be a disease associated with high mortality. Among the factors leading to poor outcomes are innate resistance to currently available therapies, advanced stage at diagnosis, and complex biology. Platinum and ionizing radiation form the backbone...
Autores principales: | Dewalt, Robin I, Kesler, Kenneth A, Hammoud, Zane T, Baldridge, LeeAnn, Hattab, Eyas M, Jalal, Shadia I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217507/ https://www.ncbi.nlm.nih.gov/pubmed/28210138 http://dx.doi.org/10.2147/LCTT.S57594 |
Ejemplares similares
-
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
por: Mamdani, Hirva, et al.
Publicado: (2021) -
Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
por: Schulz, Christoph, et al.
Publicado: (2020) -
Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
por: Perkhofer, Lukas, et al.
Publicado: (2019) -
Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities
por: Krasikova, Yuliya, et al.
Publicado: (2021) -
Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcoma
por: Jin, Guojun, et al.
Publicado: (2015)